Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28874589.
- Also identified by DOI 10.1073/pnas.1705768114 and PMC identifier 5617277.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
G protein-coupled receptors (GPCRs) are classically characterized as cell-surface receptors transmitting extracellular signals into cells. Here we show that central components of a GPCR signaling system comprised of the melatonin type 1 receptor (MT<sub>1</sub>), its associated G protein, and β-arrestins are on and within neuronal mitochondria. We discovered that the ligand melatonin is exclusively synthesized in the mitochondrial matrix and released by the organelle activating the mitochondrial MT<sub>1</sub> signal-transduction pathway inhibiting stress-mediated cytochrome <i>c</i> release and caspase activation. These findings coupled with our observation that mitochondrial MT<sub>1</sub> overexpression reduces ischemic brain injury in mice delineate a mitochondrial GPCR mechanism contributing to the neuroprotective action of melatonin. We propose a new term, "automitocrine," analogous to "autocrine" when a similar phenomenon occurs at the cellular level, to describe this unexpected intracellular organelle ligand-receptor pathway that opens a new research avenue investigating mitochondrial GPCR biology.
Medical subject headings
- Brain Injuries
- Brain Ischemia
- Melatonin
- Mitochondria
- Receptor, Melatonin, MT1
- Signal Transduction